{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:15:42Z","timestamp":1783520142886,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82373403"],"award-info":[{"award-number":["No. 82373403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12230-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:17:59Z","timestamp":1783516679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IQGAP2 regulates phagocytic-like activity and PD-L1 expression in glioma through the JAK2\/STAT3 axis"],"prefix":"10.1007","volume":"53","author":[{"given":"Yuduo","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"12230_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM et al (2024) Glioma. Nat Rev Dis Prim 10:33. https:\/\/doi.org\/10.1038\/s41572-024-00516-y","journal-title":"Nat Rev Dis Prim"},{"key":"12230_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY et al (2020) Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"CA Cancer J Clin"},{"key":"12230_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H et al (2024) Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol 21:1354\u20131375. https:\/\/doi.org\/10.1038\/s41423-024-01226-x","journal-title":"Cell Mol Immunol"},{"key":"12230_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A et al (2024) Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol 17:31. https:\/\/doi.org\/10.1186\/s13045-024-01544-7","journal-title":"J Hematol Oncol"},{"key":"12230_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","volume":"11","author":"E Uribe-Querol","year":"2020","unstructured":"Uribe-Querol E, Rosales C (2020) Phagocytosis: Our Current Understanding of a Universal Biological Process. Front Immunol 11:1066. https:\/\/doi.org\/10.3389\/fimmu.2020.01066","journal-title":"Front Immunol"},{"key":"12230_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545:495\u2013499. https:\/\/doi.org\/10.1038\/nature22396","journal-title":"Nature"},{"key":"12230_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41392-023-01365-z","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang Y, Yang Y et al (2023) Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduct Target Ther 8:104. https:\/\/doi.org\/10.1038\/s41392-023-01365-z","journal-title":"Signal Transduct Target Ther"},{"key":"12230_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00893-w","author":"A Veillette","year":"2025","unstructured":"Veillette A, Li J, Galindo CC et al (2025) Targeting phagocytosis checkpoints for cancer immunotherapy. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-025-00893-w","journal-title":"Nat Rev Cancer"},{"key":"12230_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","volume":"19","author":"M Feng","year":"2019","unstructured":"Feng M, Jiang W, Kim BYS et al (2019) Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer 19:568\u2013586. https:\/\/doi.org\/10.1038\/s41568-019-0183-z","journal-title":"Nat Rev Cancer"},{"key":"12230_CR10","doi-asserted-by":"publisher","first-page":"R619","DOI":"10.1016\/j.cub.2021.01.036","volume":"31","author":"S Mylvaganam","year":"2021","unstructured":"Mylvaganam S, Freeman SA, Grinstein S (2021) The cytoskeleton in phagocytosis and macropinocytosis. Curr Biol 31:R619\u2013R632. https:\/\/doi.org\/10.1016\/j.cub.2021.01.036","journal-title":"Curr Biol"},{"key":"12230_CR11","doi-asserted-by":"publisher","first-page":"e34474","DOI":"10.1016\/j.heliyon.2024.e34474","volume":"10","author":"G Han","year":"2024","unstructured":"Han G, Wang X, Pu K et al (2024) Identification of a prognosis-related phagocytosis regulator gene signature in medulloblastoma. Heliyon 10:e34474. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34474","journal-title":"Heliyon"},{"key":"12230_CR12","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.3390\/ijms231810312","volume":"23","author":"J Feng","year":"2022","unstructured":"Feng J, Ren J, Li X et al (2022) Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients. Int J Mol Sci 23:10312. https:\/\/doi.org\/10.3390\/ijms231810312","journal-title":"Int J Mol Sci"},{"key":"12230_CR13","doi-asserted-by":"publisher","first-page":"41237","DOI":"10.1074\/jbc.M304838200","volume":"278","author":"JM Mataraza","year":"2003","unstructured":"Mataraza JM, Briggs MW, Li Z et al (2003) IQGAP1 Promotes Cell Motility and Invasion. J Biol Chem 278:41237\u201341245. https:\/\/doi.org\/10.1074\/jbc.M304838200","journal-title":"J Biol Chem"},{"key":"12230_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/d41586-026-00123-9","volume":"649","author":"L Dattaro","year":"2026","unstructured":"Dattaro L (2026) Cancer might evade immune defences by stealing mitochondria. Nature 649:1090\u20131090. https:\/\/doi.org\/10.1038\/d41586-026-00123-9","journal-title":"Nature"},{"key":"12230_CR15","doi-asserted-by":"publisher","unstructured":"Thines L, Roushar FJ, Hedman AC, Sacks DB (2023) The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling. J Cell Biol 222. https:\/\/doi.org\/10.1083\/jcb.202205062","DOI":"10.1083\/jcb.202205062"},{"key":"12230_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/cancers15041115","volume":"15","author":"F Song","year":"2023","unstructured":"Song F, Dai Q, Grimm M-O, Steinbach D (2023) The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers. Cancers (Basel) 15:1115. https:\/\/doi.org\/10.3390\/cancers15041115","journal-title":"Cancers (Basel)"},{"key":"12230_CR17","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nrm2504","volume":"9","author":"M Overholtzer","year":"2008","unstructured":"Overholtzer M, Brugge JS (2008) The cell biology of cell-in-cell structures. Nat Rev Mol Cell Biol 9:796\u2013809. https:\/\/doi.org\/10.1038\/nrm2504","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12230_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"12230_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-021-03879-4","volume":"597","author":"RA Kamber","year":"2021","unstructured":"Kamber RA, Nishiga Y, Morton B et al (2021) Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis. Nature 597:549\u2013554. https:\/\/doi.org\/10.1038\/s41586-021-03879-4","journal-title":"Nature"},{"key":"12230_CR20","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41588-018-0254-1","volume":"50","author":"MS Haney","year":"2018","unstructured":"Haney MS, Bohlen CJ, Morgens DW et al (2018) Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. Nat Genet 50:1716\u20131727. https:\/\/doi.org\/10.1038\/s41588-018-0254-1","journal-title":"Nat Genet"},{"key":"12230_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/cells14131035","volume":"14","author":"M Kikuchi","year":"2025","unstructured":"Kikuchi M, Takami H, Kobayashi Y et al (2025) Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy. Cells 14:1035. https:\/\/doi.org\/10.3390\/cells14131035","journal-title":"Cells"},{"key":"12230_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7:41\u201351. https:\/\/doi.org\/10.1038\/nri1995","journal-title":"Nat Rev Immunol"},{"key":"12230_CR23","doi-asserted-by":"publisher","first-page":"1123853","DOI":"10.3389\/fimmu.2023.1123853","volume":"14","author":"C Lin","year":"2023","unstructured":"Lin C, Wang N, Xu C (2023) Glioma-associated microglia\/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy. Front Immunol 14:1123853. https:\/\/doi.org\/10.3389\/fimmu.2023.1123853","journal-title":"Front Immunol"},{"key":"12230_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41587-020-0532-1","volume":"38","author":"JG Yeo","year":"2020","unstructured":"Yeo JG, Wasser M, Kumar P et al (2020) The Extended Polydimensional Immunome Characterization (EPIC) web-based reference and discovery tool for cytometry data. Nat Biotechnol 38:679\u2013684. https:\/\/doi.org\/10.1038\/s41587-020-0532-1","journal-title":"Nat Biotechnol"},{"key":"12230_CR25","doi-asserted-by":"publisher","first-page":"1561388","DOI":"10.3389\/fimmu.2025.1561388","volume":"16","author":"Y Fu","year":"2025","unstructured":"Fu Y, Yi Y, Shao Y et al (2025) Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptations. Front Immunol 16:1561388. https:\/\/doi.org\/10.3389\/fimmu.2025.1561388","journal-title":"Front Immunol"},{"key":"12230_CR26","doi-asserted-by":"publisher","first-page":"1452172","DOI":"10.3389\/fimmu.2024.1452172","volume":"15","author":"Z He","year":"2024","unstructured":"He Z, Liu Z, Wang Q et al (2024) Single-cell and spatial transcriptome assays reveal heterogeneity in gliomas through stress responses and pathway alterations. Front Immunol 15:1452172. https:\/\/doi.org\/10.3389\/fimmu.2024.1452172","journal-title":"Front Immunol"},{"key":"12230_CR27","doi-asserted-by":"publisher","unstructured":"Venteicher AS, Tirosh I, Hebert C et al (2017) Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (80-) 355:. https:\/\/doi.org\/10.1126\/science.aai8478","DOI":"10.1126\/science.aai8478"},{"key":"12230_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbamcr.2018.03.004","volume":"1865","author":"J Durgan","year":"2018","unstructured":"Durgan J, Florey O (2018) Cancer cell cannibalism: Multiple triggers emerge for entosis. Biochim Biophys Acta - Mol Cell Res 1865:831\u2013841. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.03.004","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"12230_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41568-018-0073-9","volume":"18","author":"S Fais","year":"2018","unstructured":"Fais S, Overholtzer M (2018) Cell-in-cell phenomena in cancer. Nat Rev Cancer 18:758\u2013766. https:\/\/doi.org\/10.1038\/s41568-018-0073-9","journal-title":"Nat Rev Cancer"},{"key":"12230_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.15252\/embr.201439834","volume":"16","author":"AC Hedman","year":"2015","unstructured":"Hedman AC, Smith JM, Sacks DB (2015) The biology of IQGAP proteins: beyond the cytoskeleton. EMBO Rep 16:427\u2013446. https:\/\/doi.org\/10.15252\/embr.201439834","journal-title":"EMBO Rep"},{"key":"12230_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/imr.12212","volume":"262","author":"SA Freeman","year":"2014","unstructured":"Freeman SA, Grinstein S (2014) Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev 262:193\u2013215. https:\/\/doi.org\/10.1111\/imr.12212","journal-title":"Immunol Rev"},{"key":"12230_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41420-024-01877-9","volume":"10","author":"K\u0410 Gaptulbarova","year":"2024","unstructured":"Gaptulbarova K\u0410, Tsydenova IA, Dolgasheva DS et al (2024) Mechanisms and significance of entosis for tumour growth and progression. Cell Death Discov 10:109. https:\/\/doi.org\/10.1038\/s41420-024-01877-9","journal-title":"Cell Death Discov"},{"key":"12230_CR33","doi-asserted-by":"publisher","first-page":"e1086862","DOI":"10.1080\/2162402X.2015.1086862","volume":"5","author":"S Spranger","year":"2016","unstructured":"Spranger S, Gajewski TF (2016) Tumor-intrinsic oncogene pathways mediating immune avoidance. Oncoimmunology 5:e1086862. https:\/\/doi.org\/10.1080\/2162402X.2015.1086862","journal-title":"Oncoimmunology"},{"key":"12230_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M et al (2019) CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572:392\u2013396. https:\/\/doi.org\/10.1038\/s41586-019-1456-0","journal-title":"Nature"},{"key":"12230_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cancers13030437","volume":"13","author":"A Ou","year":"2021","unstructured":"Ou A, Ott M, Fang D, Heimberger A (2021) The Role and Therapeutic Targeting of JAK\/STAT Signaling in Glioblastoma. Cancers (Basel) 13:437. https:\/\/doi.org\/10.3390\/cancers13030437","journal-title":"Cancers (Basel)"},{"key":"12230_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8:204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Ther"},{"key":"12230_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-230X-10-125","volume":"10","author":"CD White","year":"2010","unstructured":"White CD, Khurana H, Gnatenko DV et al (2010) IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol 10:125. https:\/\/doi.org\/10.1186\/1471-230X-10-125","journal-title":"BMC Gastroenterol"},{"key":"12230_CR38","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1200\/jco.2008.26.15_suppl.4600","volume":"26","author":"VA Schmidt","year":"2026","unstructured":"Schmidt VA, Capilla E, Miller F, Bahou WF (2026) Hepatocellular carcinoma in IQGAP2-deficient mice and evaluation of IQGAP2 as a potential novel tumor suppressor gene. J Clin Oncol 26:4600. https:\/\/doi.org\/10.1200\/jco.2008.26.15_suppl.4600","journal-title":"J Clin Oncol"},{"key":"12230_CR39","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ijc.23181","volume":"122","author":"S-H Jin","year":"2008","unstructured":"Jin S-H, Akiyama Y, Fukamachi H et al (2008) IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer 122:1040\u20131046. https:\/\/doi.org\/10.1002\/ijc.23181","journal-title":"Int J Cancer"},{"key":"12230_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13059-015-0581-9","volume":"16","author":"W Zhang","year":"2015","unstructured":"Zhang W, Spector TD, Deloukas P et al (2015) Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements. Genome Biol 16:14. https:\/\/doi.org\/10.1186\/s13059-015-0581-9","journal-title":"Genome Biol"},{"key":"12230_CR41","doi-asserted-by":"publisher","first-page":"vdae174","DOI":"10.1093\/noajnl\/vdae174","volume":"6","author":"E Schonfeld","year":"2024","unstructured":"Schonfeld E, Choi J, Tran A et al (2024) The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review. Neuro-oncology Adv 6:vdae174. https:\/\/doi.org\/10.1093\/noajnl\/vdae174","journal-title":"Neuro-oncology Adv"},{"key":"12230_CR42","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1200\/JCO.2023.41.16_suppl.2060","volume":"41","author":"MS Ahluwalia","year":"2023","unstructured":"Ahluwalia MS, Ozair A, Khosla AA et al (2023) Safety and feasibility of JAK inhibitor ruxolitinib in newly-diagnosed high-grade gliomas (CRUX): Final toxicity report. J Clin Oncol 41:2060\u20132060. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.2060","journal-title":"J Clin Oncol"},{"key":"12230_CR43","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","volume":"26","author":"A Iwamaru","year":"2007","unstructured":"Iwamaru A, Szymanski S, Iwado E et al (2007) A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26:2435\u20132444. https:\/\/doi.org\/10.1038\/sj.onc.1210031","journal-title":"Oncogene"},{"key":"12230_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK (2020) The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases. Nat Rev Cancer 20:26\u201341. https:\/\/doi.org\/10.1038\/s41568-019-0205-x","journal-title":"Nat Rev Cancer"},{"key":"12230_CR45","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang W, Fan W, Lau J et al (2019) Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev 48:2967\u20133014. https:\/\/doi.org\/10.1039\/C8CS00805A","journal-title":"Chem Soc Rev"},{"key":"12230_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","volume":"4","author":"DA Reardon","year":"2016","unstructured":"Reardon DA, Gokhale PC, Klein SR et al (2016) Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model. Cancer Immunol Res 4:124\u2013135. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0151","journal-title":"Cancer Immunol Res"},{"key":"12230_CR47","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X et al (2023) TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res 51:D1425\u2013D1431. https:\/\/doi.org\/10.1093\/nar\/gkac959","journal-title":"Nucleic Acids Res"},{"key":"12230_CR48","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12230-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:18:00Z","timestamp":1783516680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12230"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12230-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of Sanbo Brain Hospital, Capital Medical University (approval number: SBNK-YJ-2021-023-02).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"1116"}}